FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

41015911000001105: Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2259471000001112 Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2259481000001114 Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Is a Oxybutynin 5mg modified-release tablets true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient Oxybutynin hydrochloride true Inferred relationship Existential restriction modifier
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) 28 tablet Has AMP True Oxybutynin 5mg modified-release tablets (A A H Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start